Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic
  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:

Amplify Weight Loss Drug & Treatment ETF (NY:THNR)

26.11 +0.00 (+0.00%)
Official Closing Price Updated: 8:00 PM EST, Jan 9, 2026 Add to My Watchlist

Price and Volume

Detailed Quote
Volume 390
Open 26.17
Bid (Size) 23.00 (100)
Ask (Size) 27.65 (200)
Prev. Close 26.11
Today's Range 26.11 - 26.17
52wk Range 18.56 - 26.35
Shares Outstanding 1,300
Dividend Yield 0.84%

Performance

YTD
+2.7%
+2.7%
1 Month
+4.2%
+4.2%
3 Month
+9.4%
+9.4%
6 Month
+13.7%
+13.7%
1 Year
+15.3%
+15.3%

Frequently Asked Questions

Is Amplify Weight Loss Drug & Treatment ETF publicly traded?
Yes, Amplify Weight Loss Drug & Treatment ETF is publicly traded.
What exchange does Amplify Weight Loss Drug & Treatment ETF trade on?
Amplify Weight Loss Drug & Treatment ETF trades on the New York Stock Exchange
What is the ticker symbol for Amplify Weight Loss Drug & Treatment ETF?
The ticker symbol for Amplify Weight Loss Drug & Treatment ETF is THNR on the New York Stock Exchange
What is the current price of Amplify Weight Loss Drug & Treatment ETF?
The current price of Amplify Weight Loss Drug & Treatment ETF is 26.11
When was Amplify Weight Loss Drug & Treatment ETF last traded?
The last trade of Amplify Weight Loss Drug & Treatment ETF was at 01/09/26 08:00 PM ET
What is the market capitalization of Amplify Weight Loss Drug & Treatment ETF?
The market capitalization of Amplify Weight Loss Drug & Treatment ETF is 33.94K
How many shares of Amplify Weight Loss Drug & Treatment ETF are outstanding?
Amplify Weight Loss Drug & Treatment ETF has 34K shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
 
 
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.